Dupilumab elicits a favorable response in type-2 inflammatory comorbidities of severe atopic dermatitis

Overview of attention for article published in Clinical and Molecular Allergy, June 2021

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 2,828 followers.

Dupilumab elicits a favorable response in type-2 inflammatory comorbidities of severe atopic dermatitis https://t.co/Kpwp6qpxUv https://t.co/GHNZuva4mP

Dupilumab elicits a favorable response in type-2 inflammatory comorbidities of severe atopic dermatitis https://t.co/4Y7iancWzf

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.